Clinica BavieraXMAD:CBAV +0.71%100 Operating Margin % is 22.69% as of Mar. 2026, which is 23% above its 10-year median of 18.41. GuruFocus rates XMAD:CBAV with a GF Score™ of 100/100 and a GF Value™ of €41.29 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 204 Medical Diagnostics & Research companies, Clinica Baviera ranks better than 87.75% on this metric.
Clinica Baviera SA operating margin is expanding. Margin expansion is usually a good sign.
The historical rank and industry rank for Clinica Baviera's Operating Margin % or its related term are showing as below:
XMAD:CBAV'
s Operating Margin % Range Over the Past 10 Years
Min: 12.67 Med: 18.41 Max: 22.85
Current: 20.09
XMAD:CBAV's Operating Margin % is ranked better than 87.75% of 204
companies
in the Medical Diagnostics & Research industry
Industry Median: -3.195
vs XMAD:CBAV: 20.09
Clinica Baviera's 5-Year Average Operating Margin % Growth Rate was 2.10% per year.
Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.
Be Aware
Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).
If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.
For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokias Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).
Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.
Clinica Baviera Operating Margin % Related Terms
Clinica Baviera Operating Margin % Historical Data
* Premium members only.
The historical data trend for Clinica Baviera's Operating Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XMAD:CBAV vs TMO, DHR, IDXX: Operating Margin % Comparison
For the Diagnostics & Research subindustry, Clinica Baviera's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Clinica Baviera Operating Margin % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Clinica Baviera's Operating Margin % distribution charts can be found below:
* The bar in red indicates where Clinica Baviera's Operating Margin % falls into.
Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.
Clinica Baviera's Operating Margin % for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Clinica Baviera (XMAD:CBAV) has a Operating Margin % of 22.69% as of Mar. 2026. Operating margin is the ratio of total operating income to net sales. View historical data on Clinica Baviera and its competitors. This is 23% above median its historical median of 18.41. Over the past decade, Clinica Baviera's Operating Margin % has ranged from 12.67 to 22.85. According to the industry distribution chart, Clinica Baviera ranks #25 out of 204 companies in the Medical Diagnostics & Research industry, placing it in the top 12.3%.
Is Clinica Baviera's Operating Margin % too high?
Clinica Baviera's current Operating Margin % of 22.69% is 23% above median its 10-year median of 18.41. Over the past 10 years, this metric has ranged from a low of 12.67 to a high of 22.85. Based on the distribution chart, Clinica Baviera ranks #25 out of 204 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, Clinica Baviera has a GF Score™ of 100/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Clinica Baviera's Operating Margin % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Clinica Baviera ranks #25 out of 204 companies for Operating Margin %. This places Clinica Baviera in the top 12% of its industry — outperforming the majority of peers. Historically, Clinica Baviera's own Operating Margin % has ranged from 12.67 to 22.85 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Medical Diagnostics & Research company?
A good Operating Margin % depends on the Medical Diagnostics & Research industry context. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on Clinica Baviera and its competitors. Clinica Baviera's current Operating Margin % is 22.69%, which is 23% above median its own 10-year median of 18.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Clinica Baviera stock overvalued right now?
Based on GuruFocus' analysis, Clinica Baviera (XMAD:CBAV) is currently considered Significantly Overvalued. The stock's GF Value™ is €41.29, compared to a current price of €56.60 — trading 37.1% above its estimated fair value. The current Operating Margin % is 22.69%, which is 23% above median its 10-year median of 18.41. Clinica Baviera's overall GF Score™ is 100/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For Clinica Baviera (XMAD:CBAV), the current Operating Margin % is 22.69% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Clinica Baviera (XMAD:CBAV) Overvalued in 2026?
Based on GuruFocus' analysis, Clinica Baviera stock appears to be overvalued.
The current stock price of €56.60 is trading 37.1% above its estimated GF Value™ of €41.29.
GuruFocus considers Clinica Baviera to be Significantly Overvalued.
Key valuation signals for XMAD:CBAV:
Operating Margin %: 22.69% (23% above median its 10-year median of 18.41)
GF Value™: €41.29 vs. price of €56.60 (37.1% above fair value)
No single metric tells the full story. See the XMAD:CBAV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Clinica Baviera SA operates ophthalmological clinics. It is involved in the diagnosis, treatment, and monitoring of various types of ophthalmological disorders. It offers diagnosis and treatment for various eye problems such as long-sightedness, short-sightedness, astigmatism, cataracts and eye strain.
100GF Score
Get the complete analysis for XMAD:CBAV
Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XMAD:CBAV has been successfully added to your 
